Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 16;13(5):1209.
doi: 10.3390/biomedicines13051209.

Stem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future Directions

Affiliations
Review

Stem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future Directions

Nicholas T Le et al. Biomedicines. .

Abstract

Myocardial infarction (MI) is a leading cause of morbidity worldwide, resulting from ischemic damage and necrosis to cardiomyocytes. While the standard treatment regimen for MI can be successful in restoring coronary perfusion, it typically does not resolve myocardial damage, which can leave patients particularly vulnerable to complications such as heart failure or electrical conduction abnormalities. Stem cell therapies offer a promising novel approach aimed at restoring cardiac function and decreasing the incidence of functional complications after an MI. This review used a literature search to evaluate the current landscape of stem cell therapy for post-MI recovery and focuses on the stem cell candidates for MI recovery therapy, delivery methods of such treatment, and their effectiveness. Both preclinical and clinical trials have demonstrated the safety of stem cells, but have struggled with limited cell retention, inconsistent efficacy, and survival. Mechanisms are employed by stem cells to promote regeneration, such as paracrine signaling, angiogenesis, and structural remodeling, in addition to the various stem cell delivery methods, including intracoronary infusion, direct myocardial injection, and intravenous administration. Furthermore, some strategies to combat past challenges in this field are discussed; for instance, extracellular vesicles, bioengineered patches, hydrogels, gene editing, and bioprinting. This article will provide a framework for future research in stem cell therapies and highlight the current progress in the field.

Keywords: cardiac regeneration; cell-based therapy; myocardial infarction; regenerative medicine; stem cell therapy; tissue engineering.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Overview of the most prominent stem cell population origins for post-MI therapies. Autologous origin is indicated by the “Auto” tag, and allogeneic origin is indicated by the “Allo” tag. Created in Biorender. Le. (2025) https://app.biorender.com/illustrations/67d20536719d6d5bbe39b236 (accessed on 30 March 2025).

References

    1. Mathers C.D., Boerma T., Ma Fat D. Global and Regional Causes of Death. Br. Med. Bull. 2009;92:7–32. doi: 10.1093/bmb/ldp028. - DOI - PubMed
    1. Ojha N., Dhamoon A.S. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2025. Myocardial Infarction. - PubMed
    1. Le N.T., Dunleavy M.W., Kumar R.D., Zhou W., Bhatia S.S., El-Hashash A.H. Cellular Therapies for Idiopathic Pulmonary Fibrosis: Current Progress and Future Prospects. Am. J. Stem Cells. 2024;13:191–211. doi: 10.62347/DAKS5508. - DOI - PMC - PubMed
    1. du Pré B.C., Doevendans P.A., van Laake L.W. Stem Cells for Cardiac Repair: An Introduction. J. Geriatr. Cardiol. JGC. 2013;10:186–197. doi: 10.3969/j.issn.1671-5411.2013.02.003. - DOI - PMC - PubMed
    1. Mirotsou M., Jayawardena T.M., Schmeckpeper J., Gnecchi M., Dzau V.J. Paracrine Mechanisms of Stem Cell Reparative and Regenerative Actions in the Heart. J. Mol. Cell. Cardiol. 2011;50:280–289. doi: 10.1016/j.yjmcc.2010.08.005. - DOI - PMC - PubMed

LinkOut - more resources